Cardiogenic shock complicating acute myocardial infarction - a review

References

• Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Calif RM, Berger PB, Topol EJ. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol 1995; 26:668–74.
   Google Scholar
• Hasdai D, Topol EJ, Calif RM, Berger PB, Holmes DR Jr. Cardiogenic shock complicating acute coronary syndromes. Lancet 2000; 356: 749–56.
   Google Scholar
• Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM.Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340:1162–8.
   Google Scholar
• Hasdai D, Holmes DR Jr, Topol EJ, Berger PB, Criger DA, Hochman JS, Bates ER, Vahanian A, Armstrong PW, Wilcox R, Ohman EM, Calif RM. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III Conclusion. Eur Heart J 1999; 20:128–35.
   Google Scholar
• Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, Goldberger M, Hochman JS. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol 2000; 36:1123–9.
   Google Scholar
• Hasdai D, Harrington RA, Hochman JS, Calif RM, Battler A, Box JW, Simoons ML, Deckers J, Topol EJ, Holmes DR Jr. Platelet glycoprotein Ilb/Illa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2000; 36:685–92.
   Google Scholar
• Holmes DR Jr, Berger PB, Hochman JS, Granger CB, Thompson TD, Calif RM, Vahanian A, Bates ER, Topol EJ. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999; 100:2067–73.
   Google Scholar
• Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005; 294: 448–54.
   Google Scholar
• Silver 5, Albertsson P. Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P. Stone GW, Wijns W; Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary intervention. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804–47.
   Google Scholar
• Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O’Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V. Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report ofthe American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113:156–75.
   Google Scholar
• Antman EM, Braunwald E. Acute myocardial infarction. In: Braunwald E, Fauci A, Kasper D, et al, eds. Harrison’s Principles of Internal Medicine. 15th ed. New York, NY: McGraw-Hill; 2001:1395.
   Google Scholar
• Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, Davidoff R, Boland J, Modur 5, Forman R, Hochman JS. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol 2003; 41: 1273–9.
   Google Scholar
• Brookes C, Ravn H, White P. Moeldrup U, Oldershaw P. Redington A.Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance. Circulation 1999; 100: 761–7.
   Google Scholar
• Zhang C, Xu X, Potter BJ, Wang W, Kuo L, Michael L, Bagby GJ, Chilian WM. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2006; 26:475–80.
   Google Scholar
• Menon V. Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report from the SHOCK trial registry. Am J Med 2000; 108: 374–80.
   Google Scholar
• Hasdai D, Holmes DR Jr, Calif RM, Thompson TD, Hochman JS, Pfisterer M, Topol EJ. Cardiogenic shock complicating acute myocardial infarction: predictors of death. Am HeartJ 1999; 138:21–31.
   Google Scholar
• Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RI, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110: 588–636.
   Google Scholar
• Leier CV, Heban PT, Huss P. Bush CA, Lewis RP. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 1978; 58: 466–75.
   Google Scholar
• Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343:311–22.
   Google Scholar
• French JK, Feldman, HA, Assmann, SF, Sanborn T, Palmeri ST, Miller D, Boland J, Buller CE, Steingart R, Sleeper LA, Hochman JS; SHOCK Investigators.Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation on 12-month survival in the SHOCK trial. Am Heart J 2003; 146:804–10.
   Google Scholar
• Roque M, Sanz GA. Treatment of cardiogenic shock with thrombolysis and coronary angioplasty. Rev Esp Cardiol 1992; 45:43–9.
   Google Scholar
• Prewitt RM, Gu 5, Schick U, Ducas J. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol 1994; 23:794–8.
   Google Scholar
• Anderson RD, Ohman EM, Holmes DR Jr, Col I, Stebbins AL, Bates ER, Stomel RJ, Granger CB, Topol EJ, Calif RM.Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: Observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30: 708–15.
   Google Scholar
• Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM; Investigators in the National Registry of Myocardial Infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141:933–39.
   Google Scholar
• Chen EW, Canto JG, Parsons LS, Peterson ED, Lithell KA, Every NR, Gibson CM, Hochman JS, Ohman EM, Cheeks M, Barron HV; Investigators in the National Registry of Myocardial Infarction 2. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation 2003; 108:951–7.
   Google Scholar
• O’Rourke MF, Norris RM, Campbell TJ, Chang VP, Sommel NL. Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol 1981; 47:815–20.
   Google Scholar
• Flaherty JT, Becker LC, Weiss JL, Brinker JA, Bulkley BH, Gerstenblith G, Kallman CH, Weisfeldt ML Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients withacute myocardial infarction. J Am Coll Cardiol 1985; 6:434–46.
   Google Scholar
• Keely EC, Boura JA, Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction, a quantitative review of 23 randomized trials. Lancet 2003; 361: 13–20.
   Google Scholar
• Zfilstra F, Hoorntje JC, de Boer MJ, Reiffers 5, Miedema K, Ottervanger JP, van I Hof AW, Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341:1413–9.
   Google Scholar
• Nunn CM, O’Neill WW, Rothbaum D, Stone GW, O’Keefe J, Overlie P. Donohue B, Grines L, Browne KF, Vlietstra RE, Catlin T, Grines CL. Long-term outcome after primary angioplasty: report from primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol 1999; 33:640–6.
   Google Scholar
• Grines CL, Serruys P. O’Neill WW. Fibrinolytic therapy: is it a treatment of the past? Circulation 2003; 107:2538–42.
   Google Scholar
• Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH.Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries forCardiogenic Shock. N Engl J Med 1999; 341:625–34.
   Google Scholar
• Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur 5, Forman R, Desvigne-Nickens P. Jacobs AK, Slater JN, LeJemtel TH; SHOCK Investigators.One-year survival following early revascularization for cardiogenic shock. JAMA 2001; 285:190–2.
   Google Scholar
• White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, Wong CK, Stewart JT, Aylward PE, Wong SC, Hochman JS. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: Results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 2005; 112: 1992–2001.
   Google Scholar